Key result
Conversion to a leadless pacemaker enabled safe left total mastectomy and axillary lymph node dissection with pacemaker resection in a patient with breast cancer located directly above an implanted pacemaker, with no recurrence at 2 years.
Why the study?
Breast cancer coexisting with a pacemaker is expected to increase with population aging, requiring individualized management strategies.
Case Report (n=1)
No
Conversion to a leadless pacemaker is a viable and safe strategy to facilitate surgical resection in patients with breast cancer located near or directly above a conventional pacemaker generator.
Answers are grounded in this paper and cite their sources.
May support individualized leadless conversion in select device-adjacent breast cancers; hypothesis-generating and requires prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Asada et al. (2023) conducted a case report in Breast cancer located directly above an implantable pacemaker (n=1). Conversion to leadless pacemaker and surgical resection was evaluated on Surgical success and recurrence. Conversion to a leadless pacemaker enabled safe left total mastectomy and axillary lymph node dissection with pacemaker resection in a patient with breast cancer located directly above an implanted pacemaker, with no recurrence at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: